Logo image of LASE

LASER PHOTONICS CORP (LASE) Stock Fundamental Analysis

NASDAQ:LASE - Nasdaq - US51807Q1004 - Common Stock - Currency: USD

3.92  +1.46 (+59.35%)

After market: 4 +0.08 (+2.04%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to LASE. LASE was compared to 127 industry peers in the Machinery industry. LASE may be in some trouble as it scores bad on both profitability and health. LASE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LASE had negative earnings in the past year.
LASE had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: LASE reported negative net income in multiple years.
In the past 5 years LASE reported 4 times negative operating cash flow.
LASE Yearly Net Income VS EBIT VS OCF VS FCFLASE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

The Return On Assets of LASE (-64.04%) is worse than 91.34% of its industry peers.
LASE has a worse Return On Equity (-149.96%) than 87.40% of its industry peers.
Industry RankSector Rank
ROA -64.04%
ROE -149.96%
ROIC N/A
ROA(3y)-26.76%
ROA(5y)-14.34%
ROE(3y)-39.66%
ROE(5y)-21.67%
ROIC(3y)N/A
ROIC(5y)N/A
LASE Yearly ROA, ROE, ROICLASE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

LASE has a better Gross Margin (45.04%) than 85.83% of its industry peers.
LASE's Gross Margin has declined in the last couple of years.
LASE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.82%
GM growth 5YN/A
LASE Yearly Profit, Operating, Gross MarginsLASE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

1

2. Health

2.1 Basic Checks

LASE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LASE has more shares outstanding
LASE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LASE Yearly Shares OutstandingLASE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M
LASE Yearly Total Debt VS Total AssetsLASE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of 0.37, we must say that LASE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.37, LASE is not doing good in the industry: 80.31% of the companies in the same industry are doing better.
LASE has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
LASE has a Debt to Equity ratio of 0.12. This is in the better half of the industry: LASE outperforms 74.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACCN/A
WACC10.02%
LASE Yearly LT Debt VS Equity VS FCFLASE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.82 indicates that LASE may have some problems paying its short term obligations.
LASE has a worse Current ratio (0.82) than 93.70% of its industry peers.
LASE has a Quick Ratio of 0.82. This is a bad value and indicates that LASE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.41, LASE is not doing good in the industry: 93.70% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.41
LASE Yearly Current Assets VS Current LiabilitesLASE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

LASE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -174.99%.
LASE shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.95%.
LASE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.59% yearly.
EPS 1Y (TTM)-174.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)43.95%
Revenue growth 3Y-6.59%
Revenue growth 5YN/A
Sales Q2Q%208.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LASE Yearly Revenue VS EstimatesLASE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LASE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LASE Price Earnings VS Forward Price EarningsLASE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LASE Per share dataLASE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LASE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LASER PHOTONICS CORP

NASDAQ:LASE (8/19/2025, 8:01:19 PM)

After market: 4 +0.08 (+2.04%)

3.92

+1.46 (+59.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-15 2025-08-15
Earnings (Next)11-10 2025-11-10
Inst Owners4.14%
Inst Owner Change-32.98%
Ins Owners1.33%
Ins Owner Change0%
Market Cap55.98M
AnalystsN/A
Price TargetN/A
Short Float %13.54%
Short Ratio1.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.28
P/FCF N/A
P/OCF N/A
P/B 8.17
P/tB 37.4
EV/EBITDA N/A
EPS(TTM)-0.92
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.68
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS0.35
BVpS0.48
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -64.04%
ROE -149.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.04%
FCFM N/A
ROA(3y)-26.76%
ROA(5y)-14.34%
ROE(3y)-39.66%
ROE(5y)-21.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.82%
GM growth 5YN/A
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.86%
Cap/Sales 4.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.41
Altman-Z 0.37
F-Score3
WACC10.02%
ROIC/WACCN/A
Cap/Depr(3y)47.74%
Cap/Depr(5y)2746.81%
Cap/Sales(3y)7.88%
Cap/Sales(5y)43.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-174.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.95%
Revenue growth 3Y-6.59%
Revenue growth 5YN/A
Sales Q2Q%208.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-125.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-312.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-320.96%
OCF growth 3YN/A
OCF growth 5YN/A